Baker Ellis Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Sell
81,342
-1,725
-2% -$77.1K 0.36% 65
2026
Q1
$4M Sell
83,067
-410
-0.5% -$19.1K 0.48% 58
2025
Q4
$4.05M Sell
83,477
-9,440
-10% -$468K 0.49% 52
2025
Q3
$4.39M Sell
92,917
-2,877
-3% -$139K 0.54% 51
2025
Q2
$4.63M Buy
95,794
+2,014
+2% +$103K 0.64% 44
2025
Q1
$5.2M Buy
93,780
+6,872
+8% +$372K 0.75% 36
2024
Q4
$4.19M Sell
86,908
-5,281
-6% -$269K 0.62% 48
2024
Q3
$5.31M Sell
92,189
-453
-0.5% -$24.5K 0.75% 41
2024
Q2
$4.49M Sell
92,642
-860
-0.9% -$41.5K 0.68% 44
2024
Q1
$4.54M Sell
93,502
-2,200
-2% -$107K 0.68% 45
2023
Q4
$4.76M Sell
95,702
-5,755
-6% -$281K 0.76% 40
2023
Q3
$5.44M Buy
101,457
+770
+0.8% +$41.1K 0.98% 30
2023
Q2
$5.43M Buy
100,687
+1,695
+2% +$91.2K 0.92% 34
2023
Q1
$5.39M Buy
+98,992
New +$4.81M 0.96% 33
2020
Q3
Sell
-2,600
Closed -$133K 193
2020
Q2
$133K Buy
+2,600
New +$126K 0.04% 172
2015
Q4
Sell
-15,595
Closed -$740K 246
2015
Q3
$740K Sell
15,595
-800
-5% -$40.7K 0.26% 99
2015
Q2
$812K Sell
16,395
-1,025
-6% -$51.9K 0.27% 98
2015
Q1
$861K Buy
17,420
+1,030
+6% +$49.2K 0.27% 96
2014
Q4
$748K Sell
16,390
-2,000
-11% -$97K 0.25% 97
2014
Q3
$1.04M Buy
18,390
+3,350
+22% +$180K 0.36% 77
2014
Q2
$800K Buy
+15,040
New +$798K 0.27% 89

Other funds holding SNY

Baker Ellis Asset Management's SNY Position: Q2 2026 in Review

Baker Ellis Asset Management reduced its Sanofi (SNY) stake by 2.1% in Q2 2026, selling an estimated $77.1K and leaving 81,342 shares worth $3.47M. The position accounts for 0.36% of the portfolio, ranked #65.

Baker Ellis Asset Management first reported a position in SNY in Q2 2014 and has held it in 21 quarters since. The position peaked at $5.44M in Q3 2023. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Baker Ellis Asset Management held 81,342 shares of Sanofi worth $3.47M as of Q2 2026.
  • Baker Ellis Asset Management sold 1,725 Sanofi shares in Q2 2026, an estimated $77.1K.
  • Sanofi made up 0.36% of Baker Ellis Asset Management's portfolio in Q2 2026, its #65 holding.
  • Baker Ellis Asset Management first reported a position in Sanofi in Q2 2014 and has held it in 21 quarters since.
  • Baker Ellis Asset Management's Sanofi position peaked at $5.44M in Q3 2023.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Baker Ellis Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.